ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
Kingalone
|
117 |
54K |
1 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
117
|
54K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Kingalone
|
1.0K |
439K |
6 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.0K
|
439K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
Kingalone
|
226 |
84K |
4 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
84K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
Kingalone
|
549 |
185K |
0 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
185K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
Kingalone
|
549 |
185K |
2 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
185K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Kingalone
|
716 |
207K |
4 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
716
|
207K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Share price today
|
|
Kingalone
|
94 |
23K |
11 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
94
|
23K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Share price today
|
|
Kingalone
|
94 |
23K |
4 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
94
|
23K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CEO Presentation to 2023 Annual General Meeting
|
|
Kingalone
|
114 |
37K |
2 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
114
|
37K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Attending AGM?
|
|
Kingalone
|
71 |
18K |
0 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
71
|
18K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
Kingalone
|
362 |
123K |
3 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
362
|
123K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
Kingalone
|
362 |
123K |
4 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
362
|
123K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
Kingalone
|
362 |
123K |
4 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
362
|
123K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
Kingalone
|
362 |
123K |
8 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
362
|
123K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Kingalone
|
184 |
49K |
3 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
184
|
49K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Crimes Against Humanity
|
|
Kingalone
|
46 |
11K |
2 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
46
|
11K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Kingalone
|
574 |
201K |
4 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
201K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Why are these shares just continuing to slump
|
|
Kingalone
|
22 |
9.3K |
5 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
22
|
9.3K
|
5
|
|
ASX - By Stock
|
ZIP |
Re:
Zip Co remains popular with savvy customers as it narrows loss by 60pc
|
|
Kingalone
|
215 |
69K |
6 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
215
|
69K
|
6
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Convertible Notes Update
|
|
Kingalone
|
33 |
10K |
2 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
33
|
10K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
News: ZIP Zip Posts FY Revenue From Ordinary Activities From Cont Ops A$693.2 Million
|
|
Kingalone
|
77 |
25K |
1 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
77
|
25K
|
1
|
|
ASX - By Stock
|
RMD |
Re:
Ann: ResMed Announces Results for the Fourth Quarter of FY2023
|
|
Kingalone
|
371 |
196K |
3 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
371
|
196K
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
CASH FLOW POSITIVE PARTY
|
|
Kingalone
|
180 |
52K |
2 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
180
|
52K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Q4 FY23 Results Update - Zip Continues to Deliver
|
|
Kingalone
|
787 |
183K |
3 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
787
|
183K
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Q4 FY23 Results Update - Zip Continues to Deliver
|
|
Kingalone
|
787 |
183K |
3 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
787
|
183K
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Q4 FY23 Results Update - Zip Continues to Deliver
|
|
Kingalone
|
787 |
183K |
3 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
787
|
183K
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
Will ZIP survive next 6 months?
|
|
Kingalone
|
23 |
7.0K |
0 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
23
|
7.0K
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
Will ZIP survive next 6 months?
|
|
Kingalone
|
23 |
7.0K |
1 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
23
|
7.0K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Q4 FY23 Results Update - Zip Continues to Deliver
|
|
Kingalone
|
787 |
183K |
4 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
787
|
183K
|
4
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives US FDA Clearance for FebriDx
|
|
Kingalone
|
420 |
132K |
3 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
420
|
132K
|
3
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives US FDA Clearance for FebriDx
|
|
Kingalone
|
420 |
132K |
18 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
420
|
132K
|
18
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives US FDA Clearance for FebriDx
|
|
Kingalone
|
420 |
132K |
2 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
420
|
132K
|
2
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives US FDA Clearance for FebriDx
|
|
Kingalone
|
420 |
132K |
8 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
420
|
132K
|
8
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives US FDA Clearance for FebriDx
|
|
Kingalone
|
420 |
132K |
1 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
420
|
132K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives US FDA Clearance for FebriDx
|
|
Kingalone
|
420 |
132K |
9 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
420
|
132K
|
9
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Change in substantial holding
|
|
Kingalone
|
36 |
16K |
1 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
36
|
16K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Change in substantial holding
|
|
Kingalone
|
36 |
16K |
1 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
36
|
16K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Kingalone
|
18 |
8.5K |
1 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
18
|
8.5K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Kingalone
|
18 |
8.5K |
4 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
18
|
8.5K
|
4
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Files Appeal To The FDA For FebriDx
|
|
Kingalone
|
40 |
11K |
2 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
40
|
11K
|
2
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Withdraws from Local Manufacturing Proposal
|
|
Kingalone
|
15 |
5.3K |
2 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
15
|
5.3K
|
2
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Voluntary Suspension
|
|
Kingalone
|
19 |
9.2K |
5 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
19
|
9.2K
|
5
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Q2 FY22 - Zip momentum continues
|
|
Kingalone
|
252 |
77K |
0 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
252
|
77K
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
Daily Price Movement / General Discussion
|
|
Kingalone
|
46K |
11M |
0 |
06/01/22 |
06/01/22 |
ASX - By Stock
|
46K
|
11M
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
Daily Price Movement / General Discussion
|
|
Kingalone
|
46K |
11M |
6 |
06/01/22 |
06/01/22 |
ASX - By Stock
|
46K
|
11M
|
6
|
|